Latest From Biotech Now

Post-Con BIO CEO Company Snapshot: Immunovaccine

Immunovaccine-logo-PMS

A few weeks ago, the BIO CEO & Investor Conference concluded in New York City. With a 30% increase in One-on-One Partnering meetings and sold out company presentations, industry execs gathered to do business, and hear the latest from innovative companies. As a precursor to the event, the company snapshot campaign highlighted a few of the companies who would be participating onsite. This year, the snapshot feature concludes with an interview from Marc Mansour, Ph.D., Chief Read More >

The One-on-One Compass  |  Leave a comment  |  Email This Post
Tags: , , , , ,

GMO Answers Piece “Random Thoughts etc”

GMO Answers

The Lowdown on GMOs: According to Science, compiled by Fourat Janabi, features contributions by public scientists, authors, farmers, science writers and journalists who answer the hard questions surrounding GMOs. It is “THE book on GMOs” intended to counter fabricated and destructive activism permeating the biotech discussion based on little more than anecdote and ideology. As an independent expert, Janabi does a notable job of collecting reliable content from reputable and credible GMO experts that can Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Partnership for Part D Access Launches Today

BIO-logo-115x76

BIO joins patient groups and other health care stakeholders today to announce the formation of the Partnership for Part D Access, a coalition committed to protecting access to necessary medications for patients in the Medicare Part D prescription drug program. The Partnership for Part D Access opposes a proposed rule from the U.S. Centers for Medicare & Medicaid Services (CMS) that would reduce the number of “protected classes” of medication in Medicare Part D, specifically Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Bioterrorism: Assessing the Threat

AB23475

Recently, the House of Representatives Homeland Security Committee Subcommittee on Emergency Preparedness, Response, and Communications held a hearing on bioterrorism and biological warfare.Tom Inglesby, MD, University of Pittsburgh Medical Center, Center for Health Security and Robert P. Kadlec, MD, Center for a New American Security, presented testimony outlining their concerns on current threats to public safety and recommendations for emergency preparedness. Drs. Inglesby and Kadlec asserted that the risk of biological attacks on the U.S. Read More >

Health, Public Policy  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

Physician Payments Sunshine Act: Collaboration Key for Doctors & Biopharmas

Jim Greenwood

In a letter to the editor on USA Today, BIO CEO Jim Greenwood and John J. Castellani, president of PhRMA, write that context must accompany the data being provided under the Physician Payments Sunshine Act: “Discovery of new and improved medicines would be impossible without collaborations between physicians and biopharmaceutical companies. Consider ongoing research and clinical trials that not only make medicines possible, but also help our understanding of disease. Biopharmaceutical professionals help physicians stay Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , , ,